Chair: Good Morning. I invite the floor to adopt the provisional agenda. No comments from the floor – adopted. Welcome to the third intersessional period of the Commission of Narcotic Drugs’ sixty-first session, the thematic segment of the Continuation of preparations for the ministerial segment of the sixty-second session of the Commission on Narcotic Drugs, to …
World Health Organization (WHO)
Side event: “Hepatitis C among people who use drugs – The global state and recommendations” is locked Hepatitis C among people who use drugs – The global state and recommendations
Judith Yates – IDHDP Annette Verster – WHO Torbjorn Brekke – Norway perspective Jean-Michel Tassie – French perspective Bikas Gurung ANPUD – PUDs perspective Celine Grillon, MDM – French NGO on drug policy The side event entitled “Hepatitis C among people who use drugs – the global state and recommendations” was chaired by Dr Judith …
Plenary: Item 5. Implementation of the international drug control treaties (Wednesday 14th Morning Session)
(a) Changes in the scope of control of substances Secretary: For Item 5a on changing in the scope of control of substances proposed scheduling recommendations initiated by the WHO. It reflects comments from governments on factors related to recommendation initiated by the WHO. The Commision will examine recommendation on 12 substances as applicable to the …
Informal NGO Dialogue with the UNODC Executive Director
Opening remarks from UNODC ED: It is good to see so many people here, and it means that what we are doing is important. The CND is an important forum. I appreciate Esbjorn’s leadership of VNGOC, and for facilitating this meeting. I also appreciate the Civil Society Task Force that worked for 2016 and must now …
Side Event: Public health dimensions of the world drug problem and WHO activities in addressing them
WHO Expert Committee on Drug Dependence Public health dimensions of the world drug problem and WHO activities in addressing them Organized by the World Health Organization. Conference Room M3 Mariangela Simao, Assistant Director General for Access to Medicines, Vaccines and Pharmaceuticals Mariangela Simao: WHO is UN specialist agency for health, established in 1948. Comprised of 194 …
Side Event: Adverse Social and Health Consequences of New Psychoactive Substances
H.E. Leigh Turner, UK Ambassador (Opening Remarks) Thank you everyone for coming to consider this important issue. New psychoactive substances are a global problem. There is growing international evidence of their public health harms, and an increasing interplay between NPS and traditional drug markets. The United Kingdom is working with partners to adapt the international …